CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Returned to the company Director returned 40,000 shares (to the company)
- 4 Open-market buy Chief Executive Officer bought 112,371 shares at $0.22 ($25,047)
- 4 Open-market buy Chief Commercial Officer bought 100,000 shares at $0.24 ($24,480)
- 4/A Open-market buy Chief Financial Officer bought 90,000 shares at $0.23 ($20,700)
- 4/A Open-market buy Chief Executive Officer bought 222,000 shares at $0.24 ($52,614)
- 4 Grant or award Chief Executive Officer acquired 222,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 90,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 9,044 shares (other)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
Page 4 of 10 · 187 filings